Small Molecule Drug Design
Small Molecule Drug Design is a computational and experimental methodology focused on discovering and optimizing low molecular weight organic compounds (typically <900 Daltons) that can modulate biological targets to treat diseases. It involves techniques like structure-based design, ligand-based design, and high-throughput screening to identify lead compounds with desired pharmacological properties. This process aims to develop safe and effective drugs that can be orally administered and have good bioavailability.
Developers should learn this methodology when working in pharmaceutical, biotechnology, or academic research settings focused on drug discovery, as it is essential for creating new therapeutics for conditions like cancer, infectious diseases, and neurological disorders. It is used in cases where small molecules are preferred over biologics due to advantages like oral administration, lower production costs, and easier storage, making it critical for projects targeting intracellular proteins or enzymes.